Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 295
Selected: 0
NCT IDTitle
NCT06514235Image-guided Brachytherapy for Vaginal Cancer (EMBRAVE)
NCT00181025Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle
NCT06505590STEpwise Research Program to Promote INGeniouS ONline Supportive Solutions in the Relief of Cancer-related Fatigue
NCT05889585Morbidity, Long-term Side Effects and Quality of Life in Germ-cell Tumor Long Survivors Treated with High-dose Chemotherapy and Autologous Stem Cell Transplant
NCT03981666Video-Based Cognitive Behavioral Therapy for Insomnia in Adults Cancer Patients and Survivors
NCT04985266A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer
NCT06642844Bevacizumab-based Chemotherapy Adapted to Bevacizumab Pharmacokinetics in 1st-line Treatment
NCT00346645A Phase II Study of Velcade® in Patients Stage IIIB OR IV Non-Small Cell Lung Cancer
NCT00935675Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment
NCT04221035High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT03010124Prognostic and Predictive Biomarkers in Ovarian Cancers
NCT03984318Predictive Markers of Immune-related Adverse Events in Patients Treated With Immune Stimulatory Drugs
NCT04823403Hepatic Intra-Arterial Administration of Ipilimumab in Combination With Intra-venous Nivolumab for Advanced Hepatocellular Carcinoma
NCT06907095Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals
NCT00936156Treatment of High-Risk Cerebral Primitive Neuroectodermal Tumors in Children Aged Over 5 Years
NCT03613194Mechanistic and Molecular Study of the Process of Metastatic Dissemination in Colorectal Cancer
NCT01837745Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?
NCT07483983Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/Resistance
NCT00002823Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer
NCT00181012Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics
NCT05902559Assessment of Novel Biomarkers in Participants Undergoing Targeted Lung Health Checks
NCT05874063Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors
NCT01706016Local Treatment by Thermic Destruction of Primitive Breast Cancer
NCT04775121Classical Monocyte Kinetics in Chronic Myelomonocytic Leukemia
NCT04826445USE OF 18FDG PET-CT TO PREDICT THE RESPONSE OF MANDIBULAR OSTEORADIONECROSIS TO THE PENTOCLO PROTOCOL WITH DOCUMENTED ANTIBIOTHERAPY
NCT02992912Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours
NCT02666612Measurement and Characterization of Circulating Endothelial Cells or Circulating Tumor Cells or Circulating DNA in Adult Patients With Metastatic Cancer
NCT02517125Evaluation of the Contribution of Transoral Robotic-assisted Surgery Using Da Vinci Xi for Head and Neck Tumors
NCT03285230The French E3N Prospective Cohort Study
NCT02839655Prospective Study Assessing Thyroidectomy Using Robot
NCT03356535Metabolic Signature of Healthy Lifestyle and HCC
NCT01701479Long Term Continuous Infusion ch14.18/CHO Plus s.c. Aldesleukin (IL-2)
NCT04794296Recommendations for the Treatment of Children With Acute Lymphoblastic Leukemia in the GFAOP
NCT00162669Bevacizumab in Advanced Hepatocellular Carcinoma
NCT04826198Safety and Efficacy of AsiDNATM, a DNA Repair Inhibitor, Administered Intravenously in Addition to PARP Inhibitors in Patients With Relapsed Platinum Sensitive Ovarian Cancer Already Treated With PARP Inhibitors Since at Least 6 Months
NCT02997332Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07591493Adjuvant Trial in Pancreatic Neuroendocrine Tumors
NCT02831530Randomized Short-term Pre-surgical Study to Assess the Effects of Abemaciclib (LY2835219) in Early Breast Cancer Patients
NCT05821790Role of the Tumor Microenvironment in Aggressive Meningiomas
NCT01282697Clinical Trial of Rapamycin and Irinotecan in Pediatric Patients With Refractory Solid Tumors
NCT02025881Study of Sequential High-dose Chemotherapy in Children With High Risk Medulloblastoma
NCT05071001Long Term Brain Toxicity of Chemotherapy in Patients Treated for a Bone TumorDuring Childhood or Adolescence
NCT00232960Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC
NCT05947903Validation of the European Oncology Quality of Life Toolkit
NCT06781996A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer
NCT01864850Non Inferiority Trial of Standard RT Versus Hypofractionated Split Course in Elderly Vulnerable Patients With HNSCC
NCT00811759Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma
NCT02517892A Prospective Trial to Study the Evolution of Clonal Architecture of Tumors From Patients Treated With Molecular Targeted Agents
NCT05267912Prospective Multicenter Study Evaluating Feasibility and Efficacy of Tumor Organoid-based Precision Medicine in Patients With Advanced Refractory Cancers
NCT01884623Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer